| Neetu Talreja, MD | |
|
4201 Saint Antoine St, Detroit, MI 48201-2153 | |
| (313) 966-7680 | |
| (313) 966-6400 |
| Full Name | Neetu Talreja |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 20 Years |
| Location | 4201 Saint Antoine St, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326206889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | M12227 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Group Pc | 5799747317 | 6 |
News Archive
Pneumonia kills more children around the world than any other disease, but the last major effort to study the causes of childhood pneumonia across many countries was conducted in the 1980's. This week, a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study gets off the ground.
Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2011.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
Researchers have developed a new mouse model that allows them to replicate normal pigment cells at the earliest stages of conversion to malignant skin cancer in humans.
Today, the Chan Zuckerberg Initiative announced more than $5 million to advance bioimaging technologies, increase access to these tools, and build capacity for biomedical researchers.
› Verified 4 days ago
| Entity Name | Allergy Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979974 PECOS PAC ID: 5799747317 Enrollment ID: O20041027000279 |
News Archive
Pneumonia kills more children around the world than any other disease, but the last major effort to study the causes of childhood pneumonia across many countries was conducted in the 1980's. This week, a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study gets off the ground.
Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2011.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
Researchers have developed a new mouse model that allows them to replicate normal pigment cells at the earliest stages of conversion to malignant skin cancer in humans.
Today, the Chan Zuckerberg Initiative announced more than $5 million to advance bioimaging technologies, increase access to these tools, and build capacity for biomedical researchers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neetu Talreja, MD 1000 N Curtis Rd, Ste 303, Boise, ID 83706 Ph: (208) 377-4000 | Neetu Talreja, MD 4201 Saint Antoine St, Detroit, MI 48201-2153 Ph: (313) 966-7680 |
News Archive
Pneumonia kills more children around the world than any other disease, but the last major effort to study the causes of childhood pneumonia across many countries was conducted in the 1980's. This week, a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study gets off the ground.
Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2011.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
Researchers have developed a new mouse model that allows them to replicate normal pigment cells at the earliest stages of conversion to malignant skin cancer in humans.
Today, the Chan Zuckerberg Initiative announced more than $5 million to advance bioimaging technologies, increase access to these tools, and build capacity for biomedical researchers.
› Verified 4 days ago
Ayman Founas, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Cfp-417, Detroit, MI 48202 Phone: 313-916-2600 | |
Dr. Mohammad Mustafa Qaqi, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3189 | |
Dr. Kaled Bazzi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Department Of Internal Medicine, Detroit, MI 48202 Phone: 313-916-1828 | |
Garrett Clark Martin, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 13901 E Jefferson Ave, Detroit, MI 48215 Phone: 313-822-0900 Fax: 313-822-0950 | |
Dr. Prathyusha Savarapu, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-8144 Fax: 313-916-4460 | |
Ibrahim Husham Mohammed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 Fax: 313-916-4460 | |
Ibrahim Mohamed Abdullah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-1888 |